Clinical evaluation of Diagnovir SARS-CoV-2 ultra-rapid antigen test performance compared to PCR-based testing

Placeholder

Publication Date

2023

Advisor

Institution Author

Esken, Gülen Güney
Can, Füsun

Co-Authors

Seymen, Ali Aytac
Gulten, Ezgi
Ozgur, Erol
Ortac, Bulend
Akdemir, Irem
Cinar, Gule
Saricaoglu, Elif Mukime
Akkus, Erman
Karahan, Zeynep Ceren
Azap, Alpay

Journal Title

Journal ISSN

Volume Title

Publisher:

Nature Portfolio

Type

Journal Article
View PlumX Details

Abstract

Coronavirus Disease-19 (COVID-19) is a highly contagious infectious disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The development of rapid antigen tests has contributed to easing the burden on healthcare and lifting restrictions by detecting infected individuals to help prevent further transmission of the virus. We developed a state-of-art rapid antigen testing system, named DIAGNOVIR, based on immune-fluorescence analysis, which can process and give the results in a minute. In our study, we assessed the performance of the DIAGNOVIR and compared the results with those of the qRT-PCR test. Our results demonstrated that the sensitivity and specificity of the DIAGNOVIR were 94% and 99.2%, respectively, with a 100% sensitivity and 96.97% specificity, among asymptomatic patients. In addition, DIAGNOVIR can detect SARS-CoV-2 with 100% sensitivity up to 5 days after symptom onset. We observed that the DIAGNOVIR Rapid Antigen Test's limit of detection (LoD) was not significantly affected by the SARS-CoV-2 variants including Wuhan, alpha (B1.1.7), beta (B.1.351), delta (B.1.617.2) and omicron (B.1.1.529) variants, and LoD was calculated as 8 x 10(2), 6.81 x 10(1.5), 3.2 x 10(1.5), 1 x 10(3), and 1 x 10(3.5) TCID50/mL, respectively. Our results indicated that DIAGNOVIR can detect all SARS-CoV-2 variants in just seconds with higher sensitivity and specificity lower testing costs and decreased turnover time.

Description

Subject

Medicine

Citation

Endorsement

Review

Supplemented By

Referenced By

Copy Rights Note